ATE534037T1 - Verwendung des proteins asc als marker für brustkrebs - Google Patents

Verwendung des proteins asc als marker für brustkrebs

Info

Publication number
ATE534037T1
ATE534037T1 AT04790451T AT04790451T ATE534037T1 AT E534037 T1 ATE534037 T1 AT E534037T1 AT 04790451 T AT04790451 T AT 04790451T AT 04790451 T AT04790451 T AT 04790451T AT E534037 T1 ATE534037 T1 AT E534037T1
Authority
AT
Austria
Prior art keywords
breast cancer
marker
asc
diagnosis
protein asc
Prior art date
Application number
AT04790451T
Other languages
English (en)
Inventor
Gabriele Pestlin
Herbert Andres
Peter Berndt
Marie-Luise Hagmann
Johann Karl
Hanno Langen
Werner Zolg
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE534037T1 publication Critical patent/ATE534037T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT04790451T 2003-10-15 2004-10-15 Verwendung des proteins asc als marker für brustkrebs ATE534037T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03023507 2003-10-15
PCT/EP2004/011597 WO2005040806A2 (en) 2003-10-15 2004-10-15 Use of protein asc as a marker for breast cancer

Publications (1)

Publication Number Publication Date
ATE534037T1 true ATE534037T1 (de) 2011-12-15

Family

ID=34486068

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04790451T ATE534037T1 (de) 2003-10-15 2004-10-15 Verwendung des proteins asc als marker für brustkrebs

Country Status (7)

Country Link
US (1) US7566542B2 (de)
EP (1) EP1676135B1 (de)
JP (1) JP4443568B2 (de)
AT (1) ATE534037T1 (de)
CA (1) CA2537662A1 (de)
ES (1) ES2377407T3 (de)
WO (1) WO2005040806A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050112622A1 (en) * 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
ES2323429T3 (es) * 2004-12-23 2009-07-15 F. Hoffmann-La Roche Ag Uso de la asc, como marcador para cancer colorrectal.
US8685400B2 (en) 2007-07-30 2014-04-01 University Of Miami Modulating inflammasome activity and inflammation in the central nervous system
GB0723179D0 (en) * 2007-11-27 2008-01-02 Immunovia Ab Diagnostic methods and arrays for use in the same
WO2010000467A1 (en) 2008-07-03 2010-01-07 F. Hoffmann-La Roche Ag Asc as a marker for lung cancer
GB201009798D0 (en) 2010-06-11 2010-07-21 Immunovia Ab Method,array and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9015198D0 (en) * 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5714350A (en) * 1992-03-09 1998-02-03 Protein Design Labs, Inc. Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
US5798266A (en) * 1996-08-27 1998-08-25 K-Quay Enterprises, Llc Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
US6579973B1 (en) 1998-12-28 2003-06-17 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6911306B1 (en) * 1999-10-18 2005-06-28 Emory University TMS1 compositions and methods of use
AU785115B2 (en) * 1999-10-18 2006-09-21 Emory University TMS1 compositions and methods of use
AU2001288921A1 (en) 2000-09-11 2002-03-26 Ciphergen Biosystems, Inc. Human breast cancer biomarkers

Also Published As

Publication number Publication date
EP1676135B1 (de) 2011-11-16
JP2007507695A (ja) 2007-03-29
WO2005040806A3 (en) 2005-07-07
CA2537662A1 (en) 2005-05-06
US20060257952A1 (en) 2006-11-16
JP4443568B2 (ja) 2010-03-31
US7566542B2 (en) 2009-07-28
ES2377407T3 (es) 2012-03-27
EP1676135A2 (de) 2006-07-05
WO2005040806A2 (en) 2005-05-06

Similar Documents

Publication Publication Date Title
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
ATE554389T1 (de) Apex als marker für lungenkrebs
ATE289685T1 (de) Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
DE602006007703D1 (de) Verbesserte immuntestverfahren
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
ATE430936T1 (de) Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
ATE462803T1 (de) Kit und verfahren zum nachweis von urothelkarzinom
ATE353544T1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
ATE359516T1 (de) Verwendung des proteins crabp ii (cellular retinoic acid-binding protein ii) als marker für brustkrebs
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome
ATE531822T1 (de) Diagnose von prostatakrebs
ATE393393T1 (de) Verwendung des proteins spee als marker für brustkrebs
ATE383418T1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
FR2894675B1 (fr) Distinction des meningites bacteriennes et virales
ATE410691T1 (de) Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome
ATE418737T1 (de) Verwendung des proteins spermidinsynthase (spee) als marker für kolorektalkarzinom
WO2005040807A3 (en) Swiprosin-2 as a breast cancer marker
WO2005124360A3 (en) Use of protein tebp as a marker for breast cancer
WO2005124354A3 (en) Use of protein ch10 as a marker for breast cancer